Form D · Biotechnology
Coya Therapeutics, Inc.
Houston, TX · CIK 0001835022
Offering snapshot reported Oct 28, 2024 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 23, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2024 | Initial | $10,000,026 | No comparison | 9 | SEC filing |
| Dec 20, 2023 | Initial | $26,484,515 | No comparison | 122 | SEC filing |
| May 20, 2022 | Initial | $10,443,970 | No comparison | 45 | SEC filing |
| Jan 5, 2021 | Initial | $10,000,000 | No comparison | 57 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $700K
- Finders' fees
- $0
- Form D file number
- 021-527969
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BTIG, LLC | 000122225 | |
| Wilmington Capital Securities, LLC | 000133839 | |
| Chardan Capital Markets LLC | 000120128 |
Source: Form D, filed Oct 28, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard Berman | Director, Executive |
| Hideki Garren | Director |
| Andrea Goldstein | Director, Executive |
| Dov Goldstein | Director |
| Fred Grossman | Executive |
| Adrian Hepner | Executive |
| Ann Lee | Director |
| Greg Mac Michael | Executive |
| Wilbur Ross | Director |
| David Snyder | Executive |
| Arun Swaminathan | Director |
| Shawn M. Titcomb | Director |
| Jani Tuomi | Director |
| Anabella Villalobos | Director |
| Dieter Weinand | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5850 San Felipe St. Suite 500
Houston, TX, 77057
Houston, TX, 77057